摘要 |
The present invention relates to new, efficient processes for the preparation of 5-(-2-oxyazolylalkylthio)-2-azacycloalkanoylaminothiazole compounds of formula I or a pharmaceutically acceptable salt thereof, wherein: R is alkyl, aryl or heteroaryl; R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>5 </SUP>are each independently hydrogen, alkyl, aryl or heteroaryl; R<SUP>6 </SUP>and R<SUP>7 </SUP>are each independently hydrogen, alkyl, aryl, heteroaryl, halogen, hydroxy or alkoxy; R<SUP>8 </SUP>is hydrogen, alkyl, aryl, heteroaryl, CONR<SUP>9</SUP>, R<SUP>10</SUP>, COR<SUP>11 </SUP>or COOR<SUP>12</SUP>; R<SUP>9</SUP>, R<SUP>10</SUP>, R<SUP>11 </SUP>and R<SUP>12 </SUP>are each independently hydrogen, alkyl or aryl; m equals 0 to 5; and n equals 0 to 5, which are novel, potent inhibitors of cyclin dependent kinases (cdks). The present invention further concerns new key intermediate compounds, a quaternary ammonium salt of formula III' and a 2-oxazolylalkyl derivative of formula IX.
|